Trenk D, Hertrich F, Winkelmann B, Glauner T, Dieterich H A, Jähnchen E
Department of Clinical Pharmacology, Rehabilitationszentrum, Bad Krozingen, Federal Republic of Germany.
J Clin Pharmacol. 1990 Mar;30(3):235-40. doi: 10.1002/j.1552-4604.1990.tb03467.x.
The aim of this study was to investigate if the concomitant administration of the positive inotropic drug enoximone (100 mg tid) has any effect on the morning through levels of the cardiac glycoside digoxin in 17 patients with congestive heart failure (NYHA II-IV). Plasma concentrations of digoxin were 1.05 +/- 0.37 ng/mL before enoximone, 0.95 +/- 0.31 ng/mL at the end of the enoximone treatment period of 1 week and 0.95 +/- 0.36 ng/mL 1 week after cessation of enoximone treatment. Thus, concomitant administration of enoximone had no effect on plasma concentrations of digoxin while on the other hand the hemodynamics as assessed by NYHA-classification and determination of the heart volume improved significantly.
本研究的目的是调查在17例充血性心力衰竭(纽约心脏协会II-IV级)患者中,同时给予正性肌力药物依诺昔酮(100mg,每日三次)是否会对强心苷地高辛的晨间血药浓度产生影响。依诺昔酮给药前地高辛的血浆浓度为1.05±0.37ng/mL,在依诺昔酮治疗1周结束时为0.95±0.31ng/mL,依诺昔酮治疗停止1周后为0.95±0.36ng/mL。因此,同时给予依诺昔酮对地高辛的血浆浓度没有影响,而另一方面,通过纽约心脏协会分级和心脏容积测定评估的血流动力学有显著改善。